Clinical Trials · NCT07547878

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Not Yet RecruitingPhase 4Semaglutide (Investigational)
Phase
Phase 4
Recruitment status
Not Yet Recruiting
Sponsor
Baylor Research Institute
Enrollment
64
Start date
Apr 2026
Locations
1 site, United States
Primary endpoint
On-study retention rate at 6 months
View Semaglutide compound reference